会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 36. 发明申请
    • DETECTION OF HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
    • 人类脐带组织细胞的检测
    • WO2013096686A1
    • 2013-06-27
    • PCT/US2012/071072
    • 2012-12-20
    • ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
    • DORAI, HaimantiFAVIS, Reyna L.YAO, XiangSUN, YuKIHM, AnthonyRASSNICK, Stefanie
    • C12N5/071G01N33/50
    • C12Q1/6888G01N33/56972G01N33/68G01N2333/70589
    • The invention relates to methods for detecting allogeneic therapeutic cells (such as human umbilical cord tissue-derived cells (hUTC)) in blood. The methods includes the steps of identifying one or more one or more markers positive for allogeneic therapeutic cells (e.g. hUTC) and one or more markers positive for human peripheral blood mononuclear cells (PBMC); providing a blood sample from a patient that has been treated with allogeneic therapeutic cells (e.g. hUTC), analyzing the sample using an assay method to detect one or more markers positive for PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC); and distinguishing between the PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC). In one embodiment, the cells are hUTC and the markers positive of hUTC include CD10 and/or CD13 and the one or more markers positive for PBMC includes CD45.
    • 本发明涉及用于检测血液中同种异体治疗细胞(如人脐带组织衍生细胞(hUTC))的方法。 所述方法包括鉴定一种或多种一种或多种同种异体治疗细胞(例如hUTC)阳性的标志物和一种或多种对外周血单核细胞(PBMC)阳性的标志物的步骤; 提供来自已经用同种异体治疗细胞(例如hUTC)治疗的患者的血液样品,使用测定方法分析样品以检测一种或多种对PBMC阳性的标志物和一种或多种同种异体治疗细胞阳性的标志物(例如hUTC) ; 并区分PBMC和同种异体治疗细胞(例如hUTC)阳性的一种或多种标志物。 在一个实施方案中,细胞是hUTC,hUTC阳性的标志物包括CD10和/或CD13,并且一个或多个对PBMC阳性的标志物包括CD45。